Current therapeutic options for glioblastoma and future perspectives

E Aquilanti, PY Wen - Expert Opinion on Pharmacotherapy, 2022 - Taylor & Francis
Introduction Glioblastoma is a malignant primary brain tumor that affects approximately
250,000 new patients per year worldwide. It is among the most difficult cancers to treat, and …

Current therapeutic options for glioblastoma and future perspectives

E Aquilanti, PY Wen - Expert opinion on pharmacotherapy, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Glioblastoma is a malignant primary brain tumor that affects approximately
250,000 new patients per year worldwide. It is among the most difficult cancers to treat, and …

Current therapeutic options for glioblastoma and future perspectives.

E Aquilanti, PY Wen - Expert Opinion on Pharmacotherapy, 2022 - europepmc.org
Glioblastoma is a malignant primary brain tumor that affects approximately 250,000 new
patients per year worldwide. It is among the most difficult cancers to treat, and 5-year …